Generic (Pemigatinib) LuciPem

Inquire / Price
  • Model Number:
    RL1220230820300
  • Brand Name:
    LuciPem
  • Origin:
    Generic drug,Laos
  • Small Orders:
    Small batches also available
  • Tags:
    AML
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    14t/bottle
  • Strength
    4.5mg
  • Compositon
    Pemigatinib
  • Treatment
    FLT3+ holangiocarcinoma,Myeloid or Lymphoid Neoplasms
  • Form
    Tablet
  • Brand
    LuciPem
  • Quantity Unit
    4.5mg*14t/bottle
  • Manufacturer
    LUCIUS PHARMACEUTICAL,Laos PDR

Pemigatinib is a type of targeted cancer drug. It is a treatment for bile duct cancer that has come back or spread to other parts of the body. This is advanced bile duct cancer. called Fibroblast Growth Factor Receptor 2 (FGFR2).

Cholangiocarcinoma

Indicated for unresectable locally advanced or metastatic cholangiocarcinoma in previously treated patients with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement

Each cycle is 21 days

13.5 mg PO qDay for 14 consecutive days followed by 7 days off therapy

Continue until disease progression or unacceptable toxicity occurs

Myeloid or Lymphoid Neoplasms

Indicated for relapsed or refractory myeloid/lymphoid neoplasms (MLNs) in adults with fibroblast growth factor receptor 1 (FGFR1) rearrangement

13.5 mg PO qDay

Continue until disease progression or unacceptable toxicity occur


Link

Poster

Top